Financial statements Bioelektra Group
Balance sheet data of BIOELEKTRA GROUP
Year
|
2018
|
2019
|
2020
|
2021
|
---|---|---|---|---|
Total assets | 29 773 970,05 | 27 651 543,90 | 25 949 678,41 | 23 238 080,97 |
A. Fixed assets | 25 177 070,49 | 23 923 968,86 | 21 282 493,51 | 16 457 664,18 |
B. Current assets | 4 596 899,56 | 3 727 575,04 | 4 667 184,90 | 6 780 416,79 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 29 773 970,05 | 27 651 543,90 | 25 949 678,41 | 23 238 080,97 |
A. Equity | -18 524 446,41 | -22 091 505,06 | -22 572 976,46 | -25 550 816,56 |
B. Liabilities and provisions for liabilities | 48 298 416,46 | 49 743 048,96 | 48 522 654,87 | 48 788 897,53 |
I. Long-term liabilities | 20 167 810,67 | 38 920 738,17 | 21 394 233,25 | 20 726 576,15 |
II. Short-term liabilities | 26 652 628,20 | 9 510 324,84 | 26 377 018,24 | 27 486 414,81 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.